Skip to main content

Rocephin News

Antibiotic Noninferior to Ceftriaxone + Azithromycin for Gonorrhea

MONDAY, April 21, 2025 – For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone plus azithromycin, according to a study...

FDA Medwatch Alert: Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g...

FDA Medwatch Alert: Rocephin (ceftriaxone sodium) for Injection

[Posted 07/05/2007] Roche and FDA informed healthcare professionals of revisions to the CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and DOSAGE AND ADMINISTRATION sections of the...

FDA Medwatch Alert: Ceftriaxone (marketed as Rocephin and generics)

[Posted 04/14/2009] FDA notified healthcare professionals of an update to a previous alert that addresses the interaction of ceftriaxone with calcium-containing products, based on previously reported...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Bacterial Infection, Bronchitis, Eye Conditions, Gastroenteritis, Kidney Infections, Lyme Disease, Otitis Media, Pneumonia, Prostatitis, Skin and Structure Infection, Skin Infection, Urinary Tract Infection

Rocephin patient information at Drugs.com